NCT Number: NCT05738005
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.
The main question it aims to answer is:
Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients
Participants will be asked to:
* Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Detroit, Michigan, 48201, United States
Location status: Recruiting
Abdul Khan, M.D.
SUB_INVESTIGATOR
Andrew Kin, M.D.
SUB_INVESTIGATOR
Felicity WK Harper, PhD
SUB_INVESTIGATOR
Jacob Katzman
SUB_INVESTIGATOR
Jeffrey Zonder, MD
CONTACT
Jennifer Beebe-Dimmer, PhD
SUB_INVESTIGATOR
Navid Mahabadi, D.O.
SUB_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.
Time frame: 56 days
The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.
Time frame: 63 days (= 56 days + Week 10)
The subsequent adherence is the status of data recording per day during the third phase (Week 10) of trial participation (i.e., 7 days); The subsequent adherence rate will be calculated by the ratio of the number of days of adherence during the third phase (Week 10) of trial participation (i.e., 7 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.
Contact information is provided by the study sponsor or research team.
Barbara Ann Karmanos Cancer Institute
Other
DRITA Pilot Trial: Dietary Reporting in the Amyloidoses
Acronym: DRITA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT07224672
Amyloidosis, Immune System Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT06563895
Alzheimer Disease, Amyloid Cardiomyopathy
La Jolla, California, United States
View Trial DetailsNCT04636684
Amyloidosis, Metabolic Diseases
Toulouse, France
View Trial Details